Company / Current Assets
Century Therapeutics, Inc. Current Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$120.8M
FY2025
5-year range
$120.8M / $319.7M
FY2022-FY2025
Trend
-37.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $177M to $121M over the past 2 years.
Based on SEC 10-K filings.
$121M in FY2025 with a 3-year CAGR of -27.7%.
Declined from $177M to $121M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -27.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -27.7%, indicating a declining trend.
- In FY2025, current assets decreased 37.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $120.8M | -37.8% |
| FY2024 | $194.1M | +9.6% |
| FY2023 | $177.0M | -44.6% |
| FY2022 | $319.7M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026